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The relationship between a microfinance-
based healthcare delivery platform, health
insurance coverage, health screenings, and
disease management in rural Western
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Sina Kianersi1, Jane Namae10, Jeremiah Laktabai2,3 and Sonak Pastakia2,7
Abstract
Background: Structural barriers often prevent rural Kenyans from receiving healthcare and diagnostic testing. The
Bridging Income Generation through grouP Integrated Care (BIGPIC) Family intervention facilitates microfinance
groups, provides health screenings and treatment, and delivers education about health insurance coverage to
address some of these barriers. This study evaluated the association between participation in BIGPIC microfinance
groups and health screening/disease management outcomes.
Methods: From November 2018 to March 2019, we interviewed a sample of 300 members of two rural
communities in Western Kenya, 100 of whom were BIGPIC microfinance members. We queried participants about
their experiences with health screening and disease management for HIV, diabetes, hypertension, tuberculosis, and
cervical cancer. We used log-binomial regression models to estimate the association between microfinance
membership and each health outcome, adjusting for key covariates.
Results: Microfinance members were more likely to be screened for most of the health conditions we queried,
including those provided by BIGPIC [e.g. diabetes: aPR (95% CI): 3.46 (2.60, 4.60)] and those not provided [e.g.
cervical cancer: aPR (95% CI): 2.43 (1.21, 4.86)]. Microfinance membership was not significantly associated with
health insurance uptake and disease management outcomes.
Conclusions: In rural Kenya, a microfinance program integrated with healthcare delivery may be effective at
increasing health screening. Interventions designed to thoughtfully and sustainably address structural barriers to
healthcare will be critical to improving the health of those living in low-resource settings.
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Background
Low- and middle-income countries (LMICs) are gener-
ally characterized by higher mortality rates and lower life
expectancy compared to high-income countries [1].
Kenya is no exception with an average life expectancy of
63 years, placing it in the bottom quartile of all countries
[2]. This high mortality is often attributed to a high bur-
den of infectious diseases [3–6]. Overall, 5.6% of the
Kenyan population is living with HIV, [7] with a dispro-
portionate burden among women [2, 8]. Kenya also
ranks among the 14 countries with the highest burden
of TB, multidrug-resistant TB, and TB/HIV co-infection
[9]. Non-communicable disease (NCDs) also pose a
growing health threat [6, 10, 11]. In 2014, NCDs
accounted for 27% of all deaths in the country [12, 13].
Nearly a third of Kenyans have high blood pressure, and
diabetes is rapidly increasing in the country [12, 14].
Despite the high burden of infectious diseases and in-
creasing burden of NCDs in Kenya, healthcare service
utilization remains low [15]. One significant barrier to
healthcare consistently identified across LMICs is poverty.
Poverty can suppress healthcare access through inability
to afford services, low service availability, and geographic
accessibility issues [16, 17]. In Kenya, poverty has been as-
sociated with less healthcare utilization [18, 19] and more
than a third of the overall population was living below the
poverty line in 2016 [20]. Additionally, the Kenyan health
system is largely funded by out-of-pocket payments from
patients and efforts to address the inequity arising from
this structure have been mostly unsuccessful [21]. Thus,
poverty is a key barrier to uptake of health screening, and
the treatment and management of health conditions [22].
Universal health coverage, or the ability of all people
to obtain the quality health services they need without
suffering financial hardship, [23] may provide an effect-
ive pathway toward expanding healthcare access. In
2005, WHO member countries, of which Kenya is a
member, passed a resolution urging countries to adopt
universal health coverage and, in 2010, the government
of Kenya stated that health is a universal right [24, 25].
Yet, little progress has been made toward universal
health coverage in Kenya and only about 10–20% of the
population has health insurance [3, 21, 26]. The National
Health Insurance Fund (NHIF) is the primary source of
health insurance in the country and may represent a key
turning point for improving healthcare access [21, 27].
The package of NHIF benefits was recently expanded to
allow beneficiaries to receive comprehensive inpatient
and outpatient care in both the public and private sec-
tors [27]. The government-supported insurance is of-
fered at a low cost, providing affordable premium
payment requirements for low-income populations. Des-
pite these improvements, barriers to coverage remain,
particularly for rural, informally employed citizens who
tend to have the lowest rates of participation in NHIF
[21, 28].
In rural Western Kenya, where this study took place,
the Bridging Income Generation with GrouP Integrated
Care (BIGPIC) Family program aims to address some of
these structural barriers to healthcare in order to im-
prove screening and healthcare access for local residents
[29]. BIGPIC Family offers a combination of interven-
tions designed to synergistically improve health and
well-being, including: group-based microfinance services,
education about NHIF, point-of-care screening and
management for hypertension and diabetes, group-based
primary care delivery during microfinance meetings,
business literacy, and agricultural training (Fig. 1) [29–
31]. The microfinance groups are the platform through
which much of the BIGPIC programming and healthcare
is delivered.
We evaluated the associations between participation in
BIGPIC Family microfinance groups and (1) NHIF
coverage, (2) health screenings, and (3) disease manage-
ment outcomes. We hypothesized that participation in
the BIGPIC Family microfinance groups would have sev-
eral positive health-related outcomes, including higher
uptake of NHIF, higher uptake of disease screenings,
and improved disease management among those with a
chronic disease diagnosis.
Methods
Study population and setting
This cross-sectional study was conducted in two com-
munities of similar size (~ 15,000 population) and demo-
graphics in rural, western Kenya. These two
communities were chosen based on the level of their en-
gagement with AMPATH’s BIGPIC program at the time
of the study. AMPATH is a partnership between Moi
University, Moi Teaching and Referral Hospital, North
Fig. 1 Conceptual model of the BIGPIC Family
intervention components
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American universities led by Indiana University, and the
Kenyan Government with a mission of teaching, care
and research. BIGPIC began implementation in Commu-
nity 1 in 2016 but had not yet rolled out to Community
2 at the time of our data collection.
We drew our sample from three different study popu-
lations. First, we sampled 100 BIGPIC Family microfi-
nance group members, by targeting the full rosters of 7
groups randomly selected from all groups with at least 6
months of active membership in Community 1. Second,
we identified a sample of 100 people in Community 1.
Third, we identified a sample of 100 people in Commu-
nity 2. Both community samples were randomly sampled
from an enumeration of all community residents devel-
oped for a recent hypertension study in the area [32].
Only participants age 18 years and above were eligible.
Participants were not eligible to be interviewed twice if
they happened to be sampled for both the microfinance
group and community sample in Community 1. An a
priori power calculation was conducted for our desired
sample size of n = 300. For common outcomes (at 50%
prevalence), we maintained at least 80% power to detect
all prevalence ratios greater than 1.3. With less common
outcomes (at 10% prevalence), the effect sizes necessary
to maintain 80% power increased up to 2.2. Thus, we
were well-powered to detect even small effects with
common outcomes, but underpowered to detect small
effects with uncommon outcomes.
The microfinance groups are the platform through
which much of the BIGPIC programming is delivered.
Individual members meet regularly to take out and repay
group-funded loans, and they may choose to receive the
full complement of other available interventions, includ-
ing: 1) screening and care for diabetes and hypertension
and 2) NHIF education. Some intervention spillover to
non-microfinance community members is expected if
they engaged in health screening or NHIF training at
community-wide events.
Data collection
Between November 2018–February 2019, trained local
fieldworkers collected survey data from 300 participants.
All data were self-reported using a tablet-based, quanti-
tative survey administered in the local language of Kibu-
kusu with REDCap software. The survey covered a range
of topics including socio-demographic information,
microfinance group experience, and health screenings
(see survey instrument in Supplemental Material). All in-
terviews were conducted at home in a private area, after
obtaining informed consent. Ethical approval was pro-
vided by the Indiana University Institutional Review
Board (#1705661852) and the Moi University Institu-
tional Research and Ethics Committee (#00030702).
Key variables
BIGPIC Family microfinance group membership was the
primary exposure. Participants who self-reported being a
current member of a BIGPIC Family microfinance group
with a start date of at least 6 months prior to the inter-
view date were considered exposed. As a sensitivity ana-
lysis, we also considered duration of participation as a
continuous variable, based on the difference between
start date and interview date.
The unexposed group was composed of non-
microfinance group members of both Community 1 (the
community in which the program had already rolled
out) and Community 2 (the community in which the
program had not yet rolled out). To evaluate whether to
combine these communities for analysis, we assessed
whether there were differences between them with re-
spect to our key health outcomes and socio-
demographic characteristics. We found no statistical dif-
ferences between the two communities for our key out-
comes, and no differences in socio-demographic
characteristics with the exception of slightly different
wealth index distributions (Supplemental Table 1).
We operationalized NHIF health insurance coverage
as a potential outcome of BIGPIC Family group mem-
bership. Although NHIF education was provided
through BIGPIC microfinance groups, the groups have
not historically been used to directly enroll participants.
Participants were asked to self-report if they had active
NHIF coverage, which was confirmed with SMS mes-
sages to an NHIF information number.
As our primary health outcomes, we queried if partici-
pants had ever been screened for each of the following
health conditions: HIV, diabetes, hypertension, tubercu-
losis, and cervical cancer. BIGPIC Family routinely pro-
vides screening and care for some conditions (diabetes
and hypertension), but not others (HIV, tuberculosis,
cervical cancer). We also assessed two disease manage-
ment outcomes among the small subset of participants
who reported a diagnosis of hypertension, diabetes, or
HIV (n = 32): 1) current medication for condition, and 2)
healthcare visit to manage condition within the last 6
months.
We also collected sociodemographic data on: sex, age,
marital status, educational attainment, employment out-
side the home, and socio-economic status (SES). SES
was operationalized by querying household assets. We
calculated a weighted index of ownership of 20 items,
then categorized participants in quartiles, aligned with
the methodology of the 2014 Kenyan DHS) [33].
Statistical analysis
To understand the relationship between microfinance
group membership and each of the health insurance,
health screening, and disease management outcomes, we
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used log-binomial models to estimate prevalence ratios.
We compared unadjusted results to results adjusted for
age, sex, and marital status. To explore potential differ-
ences by sex and by SES, we ran models stratified by sex
and by household assets dichotomized at the median. In
the case of ‘0’ cell counts in the stratified analyses, we
added 0.5 to each cell. To assess whether there were
statistical differences in effect sizes by sex and SES, we
introduced an interaction term between each of sex and
household assets with microfinance group membership.
Interaction terms with Wald p-values < 0.05 indicated
statistically significant differences.
Since people who select into microfinance groups are
likely to have different personality profiles compared to
those that do not and this may also correlate with engage-
ment in health screenings and care, we conducted a sensi-
tivity analysis examining the relationships of interest among
a study population restricted to only include microfinance
group members. We then used duration of group member-
ship as a proxy for the exposure, with a cutpoint dividing
short-term members (< 12months) from long-term mem-
bers (greater than or equal to 12months). We compared
the prevalence of our health outcomes between short and
long-term members to assess whether the results were of
similar magnitude to our main findings.
Results
Overall, 300 men and women enrolled in the study. We
targeted 422 potential participants for interview, 21 were
ineligible, 2 refused, and we were unable to locate 99 for a
response rate among those eligible to participate of 75%.
Temporary outmigration for school or employment
accounted for most (62%) of those we were unable to lo-
cate. A majority of the participants were women (63%),
were currently married (73%), and did not work outside
the home in the last 30 days (80%) (Table 1). Participants
ranged in age from 18 to 96 (median age: 40) and lived in
households with, on average, 5 people. One-third of par-
ticipants were BIGPIC Family microfinance group mem-
bers. Members were more likely to be women, older, and
currently married. There were no significant differences
by microfinance membership for educational attainment,
formal employment, household assets, and household size.
Overall, 11% of all participants had active NHIF health
insurance coverage. Health screening rates varied by
condition: HIV (84%), diabetes (41%), hypertension
(64%), tuberculosis (10%), and cervical cancer (19% - cal-
culated among women only). Among those who re-
ported a diagnosis with HIV, diabetes, or hypertension
(n = 32), nearly three-quarters (72%) reported a medical
visit in the last 6 months. Just over half reported being
currently on medication for their condition (53%).
Health insurance coverage among microfinance group
members was 14% compared to 10% in non-members;
however, we did not observe a statistically significant as-
sociation [aPR (95% CI): 1.26 (0.64, 2.27)] (Table 2).
There were strong associations between microfinance
group membership and health screening. Microfinance
members were over three times as likely to report dia-
betes screening [aPR (95% CI): 3.46 (2.60, 4.60)], about
twice as likely to report hypertension screening [aPR
(95% CI): 1.96 (1.56, 2.46)], over three times as likely to
report tuberculosis screening [aPR (95% CI): 3.31 (1.56,
7.03)]. Among women, microfinance group members
were over twice as likely to report cervical cancer
screening [aPR (95% CI): 2.43 (1.21, 4.86)]. For each of
these outcomes, the unadjusted results were similar in
magnitude to the results adjusted for age, gender, and
marital status. HIV screening was also higher among
microfinance members (96%) compared to non-
members (78%); however, we did not observe statistically
significant associations between microfinance member-
ship and HIV screening [aPR (95% CI): 1.11 (0.64, 2.47)].
Among those who reported diagnoses with HIV, dia-
betes, or hypertension (n = 32), the associations between
microfinance membership and disease management out-
comes were not statistically significant (Table 2). The
prevalence ratios for the relationship between microfi-
nance group membership and both disease management
outcomes were above the null, but small in magnitude
[Medical visits within the last 6 months: aPR (95% CI):
1.20 (0.68, 2.10); Reporting current medication for their
health condition: aPR (95% CI): 1.30 (0.55, 3.08)]. Due to
the small sample size of this sub-group, our ability to
precisely measure these associations was limited.
The relationship between BIGPIC microfinance mem-
bership and the tuberculosis screening outcome was
stronger in men compared to women (Table 3, Wald p-
value = 0.05). We observed no statistical difference be-
tween men and women for the relationships between
microfinance and the other health screening and man-
agement outcomes we assessed, though small sample
sizes in the gender-stratified cells limited our ability to
estimate our results with precision. Similarly, the rela-
tionship between BIGPIC microfinance membership and
the HIV screening outcome was stronger in households
with lower assets compared to higher assets (Wald p-
value = 0.05). No statistical differences between house-
hold asset status levels were observed for the relation-
ship between microfinance and other health screening
and management outcomes.
Our sensitivity analysis operationalizing microfinance
exposure as length of membership instead of as member
vs. non-member showed point estimates in the same dir-
ection as observed in the primary analyses, though they
were not statistically significant (Table 4). Among
current microfinance members (n = 96), those with lon-
ger memberships tended to have more health insurance
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Table 1 Characteristics of the study population of 300 residents of two communities in rural western Kenya, 2018–2019
Microfinance group membershipa
Total
N = 300
Yes
N = 100
No
N = 200
P*
Socio-demographic characteristics
N (%) N (%) N (%)
Gender < 0.0001
Male 112 (37.3) 19 (19.0) 93 (46.5)
Female 188 (62.7) 81 (81.0) 107 (46.5)
Age 0.0006
< 20 24 (8.0) 1 (1.0) 23 (11.5)
20–29 51 (17.0) 11 (11.0) 40 (20.0)
30–39 68 (22.7) 32 (32.0) 36 (18.0)
40–49 76 (25.3) 30 (30.0) 46 (23.0)
50+ 81 (27.0) 26 (26.0) 55 (27.5)
Marital status < 0.0001
Never married 45 (15.1) 1 (1.0) 44 (22.1)
Currently married 219 (73.2) 84 (84.0) 135 (67.8)
Divorced/separated 35 (11.7) 15 (15.0) 20 (10.1)
Missing 1 0 1
Education 0.2
None/ Some primary 92 (30.7) 31 (31.0) 61 (30.5)
Primary 116 (38.7) 45 (45.0) 71 (35.5)
Secondary 69 (23.0) 20 (20.0) 49 (24.5)
Post-secondary 23 (7.7) 4 (4.0) 19 (9.5)
Work outside home (last 30 days) 0.4
Yes 59 (19.7) 17 (17.0) 42 (21.1)
No 240 (80.3) 83 (83.0) 157 (78.9)
Missing 1 0 1
Household asset quartileb 0.7
Q1 70 (25.6) 21 (23.6) 49 (26.5)
Q2 70 (25.6) 27 (30.3) 43 (23.2)
Q3 61 (22.3) 19 (21.4) 32 (22.7)
Q4 73 (26.6) 22 (24.7) 51 (27.6)
Missing 26 11 15
Current NHIF coverage 0.2
Yes 33 (11.0) 14 (14.1) 19 (9.5)
No 266 (89.0) 85 (85.9) 181 (90.5)
Missing 1 1 0
Household size [Mean (SD)] 5.0 (2.27) 5.2 (2.37) 4.8 (2.21) 0.2
Health screening characteristics
HIV screening < 0.0001
Yes 252 (84.0) 96 (96.0) 156 (78.0)
No 48 (16.0) 4 (4.0) 44 (22.0)
Diabetes screening < 0.0001
Yes 124 (41.3) 77 (77.0) 47 (23.5)
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coverage, higher rates of health screening, and better
disease management outcomes. The point estimates for
each of these outcomes were above the null (with the ex-
ception of the estimate for HIV screening and medical
visit within the last 6 months), though these estimates
were calculated imprecisely with wide confidence inter-
vals often spanning the null.
Discussion
In this study, we found that a microfinance program
underpinning the BIGPIC Family intervention in
western rural Kenya was strongly associated with in-
creased screening for several key health conditions.
Notably, these positive associations were observed
for conditions screened for directly by the BIGPIC
Table 1 Characteristics of the study population of 300 residents of two communities in rural western Kenya, 2018–2019 (Continued)
Microfinance group membershipa
Total
N = 300
Yes
N = 100
No
N = 200
P*
No 176 (58.7) 23 (23.0) 153 (76.5)
Hypertension screening < 0.0001
Yes 191 (63.7) 96 (96.0) 95 (47.5)
No 109 (36.3) 4 (4.0) 105 (52.5)
Tuberculosis screening 0.0001
Yes 31 (10.3) 20 (20.0) 11 (5.5)
No 269 (89.7) 80 (80.0) 189 (94.5)
Cervical cancer screening 0.005
Yes 36 (19.2) 23 (28.4) 13 (12.2)
No 152 (80.9) 58 (71.6) 94 (87.9)
Disease management outcomes, among those who report HIV, diabetes, or hypertension diagnoses (n = 32)
Medical visit in last 6 months 0.1
Yes 23 (71.9) 10 (90.9) 13 (61.9)
No 9 (28.1) 1 (9.1) 8 (38.1)
Currently taking medication 0.1
Yes 17 (53.1) 8 (72.7) 9 (42.9)
No 15 (46.9) 3 (27.3) 12 (57.1)
*p-value reported for chi-square test for categorical variables and t-test for continuous variables. P-values calculated among observations with non-missing values
aMember of BIGPIC Family microfinance group for at least 6 months prior to interview
bMeasured by adding up the self-reported value (at time of purchase) of 20 key items in participant’s household
Table 2 Relationship between microfinance group membership, health screening, and disease management, among 300 residents
of two communities in rural western Kenya, 2018–2019
Unadjusted Adjusteda
PR
(95% CI)
p aPR
(95% CI)
p
Current NHIF coverage 1.49 (0.78, 2.84) 0.2 1.26 (0.64, 2.47) 0.5
Health screening outcomes
HIV screening 1.23 (1.13, 1.34) < 0.0001 1.11 (0.96, 1.29) 0.2
Diabetes screening 3.28 (2.50, 4.30) < 0.0001 3.46 (2.60, 4.60) < 0.0001
Hypertension screening 2.02 (1.74, 2.35) < 0.0001 1.96 (1.56, 2.46) < 0.0001
Tuberculosis screening 3.64 (1.81, 7.29) 0.0003 3.31 (1.56, 7.03) 0.002
Cervical cancer screening 2.42 (1.27, 4.64) 0.008 2.43 (1.21, 4.86) 0.01
Disease management outcomes, among those diagnosed with HIV, diabetes, or hypertension (n = 32)
Medical visit in last 6 months 1.47 (1.00, 2.16) 0.05 1.20 (0.68, 2.10) 0.5
Currently taking medication 1.70 (0.92, 3.13) 0.1 1.30 (0.55, 3.08) 0.5
aAdjusted for age (categorized at above/below age 40 years), marital status (categorized as currently married vs not), and gender. As cervical cancer screening
rates were only calculated among female participants, the adjusted results for this outcome were not adjusted for gender
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program (hypertension and diabetes) as well as con-
ditions for which the BIGPIC program does not
regularly screen (tuberculosis and cervical cancer).
We also found that microfinance members tended to
have more HIV screening, better health insurance
coverage and disease management outcomes for
chronic health conditions, though these findings
were not statistically significant.
Our findings align with the generally positive results
observed in previous evaluations of the BIGPIC program
and of the broader microfinance landscape worldwide.
Many microfinance programs, like BIGPIC, have begun
integrating health training and healthcare provision into
their programs, [34, 35] and have generally found
positive health effects, particularly in sexual health and
maternal/child health arenas [35–39]. The BIGPIC pro-
gram has broad objectives to improve the overall health
and well-being of Kenyans, but has primarily focused on
addressing hypertension and diabetes management. A
recent BIGPIC evaluation found participation was asso-
ciated with increased engagement in care after a hyper-
tension or diabetes diagnosis and consequent reductions
in blood pressure [29]. Our study builds on this prior
evaluation by examining screening and management of
health conditions beyond hypertension and diabetes (i.e.
HIV, tuberculosis, cervical cancer) and by contextualiz-
ing the results with information on the relationship with
health insurance coverage uptake.
Importantly, the most robust results we observed were
for health screening outcomes, while the results for
health insurance uptake and disease management out-
comes were smaller and not statistically significant.
There are several plausible explanations for these differ-
ences. First, it is possible that these positive relationships
exist, but our limited sample size did not support their
measurement with adequate precision. Future studies
with larger samples would improve precision and clarify
the nature of these relationships. Second, education
about the benefits of NHIF health insurance coverage is
provided through BIGPIC programming; thus, we antici-
pated uptake of NHIF would be higher than the 14% we
observed among the group members. It is possible that
it will take more time for an expanding health insurance
scheme like the NHIF to gain traction in rural commu-
nities with little experience with the program [21]. Until
recently, the NHIF had more limited coverage, including
limited coverage at some of the facilities in the study
area. Thus, the low uptake observed could also be ex-
plained by residents in the area rationally choosing not
Table 3 Relationship between microfinance group membership, health screening, and disease management, stratified by gender
and socioeconomic status among 300 residents of two communities in rural western Kenya, 2018–2019
Women (n = 188)a Men (n = 112)a Low wealthb High wealthb
PR (95% CI) p PR (95% CI) p PR (95% CI) p PR (95% CI) p
Current NHIF coverage 1.61 (0.73, 3.53) 0.2 1.09 (0.26, 4.64) 0.9 1.60 (0.51, 4.97) 0.4 1.16 (0.42, 3.18) 0.8
Health screening outcomes
HIV screening 1.21 (1.08, 1.35) 0.007 1.26 (1.10, 1.44) < 0.0001 1.32 (1.16, 1.51) < 0.0001 1.11 (0.97, 1.25) 0.1
Diabetes screening 3.12 (2.16, 4.50) < 0.0001 4.00 (2.74, 5.86) < 0.0001 3.22 (2.17, 4.79) < 0.0001 3.06 (2.06, 4.54) < 0.0001
Hypertension screening 1.67 (1.40, 1.98) < 0.0001 2.67 (2.02, 3.52) < 0.0001 2.10 (1.68, 2.62) < 0.0001 1.88 (1.52, 2.33) < 0.0001
Tuberculosis screening 2.20 (1.02, 4.78) 0.02 12.23 (2.56, 58.46) 0.002 3.19 (1.24, 8.26) 0.02 3.63 (1.26, 10.43) 0.02
Cervical cancer screening – – – – – – 2.38 (0.93, 6.10) 0.07 2.35 (1.04, 5.30) 0.04
Disease management outcomes, among those diagnosed with HIV, diabetes, or hypertension (n = 32)
Medical visit in last 6 months 1.67 (0.98, 2.82) 0.06 1.20 (0.84, 1.72) 0.3 1.37 (0.82, 2.31) 0.2 1.40 (0.57, 3.42) 0.6
Currently taking medication 1.94 (0.95, 3.96) 0.07 1.00 (0.20, 4.95) 1.0 1.65 (0.77, 3.53) 0.2 1.17 (0.23, 5.95) 0.9
aWald p-values for interaction terms between gender and microfinance group membership were < 0.05 for the tuberculosis screening outcome only
bWald p-values for interaction terms between gender and household wealth asset (dichotomized at median) were < 0.05 for the HIV screening outcome only
Table 4 Association between duration of microfinance group
membershipa and key health screening and disease
management outcomes, among current microfinance group
members (n = 96)
PR
(95% CI)
p
Current NHIF coverage 1.38 (0.40, 4.75) 0.6
Health screening outcomes
HIV screening 0.94 (0.88, 1.00) 0.05
Diabetes screening 1.42 (1.01, 1.98) 0.04
Hypertension screening 1.10 (0.95, 1.28) 0.2
Tuberculosis screening 1.09 (0.42, 2.82) 0.9
Cervical cancer screening 1.28 (0.57, 2.90) 0.5
Disease management outcomes, among those diagnosed with HIV,
diabetes, or hypertension
Medical visit in last 6 months 0.83 (0.58, 1.19) 0.3
Currently taking medication 2.50 (0.85, 7.31) 0.1
aMicrofinance group membership duration cutpoint at
above/below 12months
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to purchase a product that provided them with limited
coverage [40]. NHIF uptake in the study area may naturally
expand as knowledge about the expansion of NHIF cover-
age spreads. Recently, the BIGPIC clinical team has sought
to obtain more direct integration with NHIF by incorporat-
ing BIGPIC healthcare services as part of the NHIF benefit
package. Preliminary findings show new increases in NHIF
uptake in the study community when copays are elimi-
nated. Finally, there are likely more barriers for participants
to engage in sustained and effective disease management
than for health screening at a single point in time. Further,
health screening was integrated into the BIGPIC Family
program earlier than the disease management components,
so participants have had more time to reap the benefits
from screening. Programmatic focus on better integrating
treatment delivery into BIGPIC Family and in reducing fi-
nancial and logistical barriers to treatment is ongoing.
Importantly, our findings do not estimate the isolated
impact of exposure to microfinance, but rather exposure
to the comprehensive suite of interventions the BIGPIC
Family program delivers through a microfinance plat-
form. Thus, our ability to understand the mechanisms
through which the program operates is limited. Future
evaluations should concentrate on understanding the
relative impact of each component of the intervention
and identifying the optimal set of interventions to pro-
duce the largest health impact.
There are several aspects of the study design that warrant
cautious interpretation of our findings. First, the cross-
sectional design prevented us from establishing temporal
relationships between the exposure and the outcomes with
certainty. Although we attempted to minimize this concern
by asking many of our survey questions in reference to spe-
cific time periods, reverse causal interpretations of our find-
ings are still plausible. Second, our health screening and
disease management outcomes were self-reported by par-
ticipants. Social desirability bias may have influenced our
results. Finally, though we controlled for several potential
confounders in our analyses, unmeasured confounding may
still have influenced our estimates. We examined the po-
tential magnitude of this issue with a sensitivity analysis
using an alternate microfinance exposure definition, mem-
bership duration. This analysis produced similar findings to
our main analyses, providing some reassurance that our
findings are robust to bias from unmeasured confounding.
Future studies with longitudinal follow-up, matching on
key sociodemographic characteristics, randomized expo-
sures, and/or healthcare outcomes extracted from medical
records will be able to provide clearer insights into the rela-
tionships we observed.
Conclusions
Our study provides preliminary evidence that microfi-
nance programs, like the one underpinning the BIGPIC
Family intervention, may have the capacity to increase
screening and disease management for some key dis-
eases. Increased screening can dramatically decrease the
public health burden of diseases through earlier detec-
tion and engagement in care [41]. Similar programs that
address barriers to healthcare at multiple levels should
be prioritized for further evaluation. Combined microfi-
nance and healthcare delivery programs can be
resource-intensive, but may be made more financially
sustainable through expanded health insurance coverage.
Ongoing efforts should be made to increase health in-
surance uptake to sustain novel healthcare delivery
models like BIGPIC Family and to realize the potential
health benefits coverage may provide.
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